Ichinose H, Ohye T, Matsuda Y, Hori T, Blau N, Burlina A, Rouse B, Matalon R, Fujita K, Nagatsu T
Institute for Comprehensive Medical Science, Fujita Health University, Aichi, Japan.
J Biol Chem. 1995 Apr 28;270(17):10062-71. doi: 10.1074/jbc.270.17.10062.
GTP cyclohydrolase I is the first and rate-limiting enzyme for the biosynthesis of tetrahydrobiopterin in mammals. Previously, we reported three species of human GTP cyclohydrolase I cDNA in a human liver cDNA library (Togari, A., Ichinose, H., Matsumoto, S., Fujita, K., and Nagatsu, T. (1992) Biochem. Biophys. Res. Commun. 187, 359-365). Furthermore, very recently, we found that the GTP cyclohydrolase I gene is causative for hereditary progressive dystonia with marked diurnal fluctuation, also known as DOPA-responsive dystonia (Ichinose, H., Ohye, T., Takahashi, E., Seki, N., Hori, T., Segawa, M., Nomura, Y., Endo, K., Tanaka, H., Tsuji, S., Fujita, K., and Nagatsu, T. (1994) Nature Genetics 8, 236-242). To clarify the mechanisms that regulate transcription of the GTP cyclohydrolase I gene and to generate multiple species of mRNA, we isolated genomic DNA clones for the human and mouse GTP cyclohydrolase I genes. Structural analysis of the isolated clones revealed that the GTP cyclohydrolase I gene is encoded by a single copy gene and is composed of six exons spanning approximately 30 kilobases. We sequenced all exon/intron boundaries of the human and mouse genes. Structural analysis also demonstrated that the heterogeneity of GTP cyclohydrolase I mRNA is caused by an alternative usage of the splicing acceptor site at the sixth exon. The transcription start site of the mouse GTP cyclohydrolase I gene and the 5'-flanking sequences of the mouse and human genes were determined. We performed regional mapping of the mouse gene by fluorescence in situ hybridization, and the mouse GTP cyclohydrolase I gene was assigned to region C2-3 of mouse chromosome 14. We identified missense mutations in patients with GTP cyclohydrolase I deficiency and expressed mutated enzymes in Escherichia coli to confirm alterations in the enzyme activity.
GTP环化水解酶I是哺乳动物中四氢生物蝶呤生物合成的首个限速酶。此前,我们在人肝脏cDNA文库中报道了三种人类GTP环化水解酶I的cDNA(Togari, A., Ichinose, H., Matsumoto, S., Fujita, K., and Nagatsu, T. (1992) Biochem. Biophys. Res. Commun. 187, 359 - 365)。此外,最近我们发现GTP环化水解酶I基因是导致遗传性进行性肌张力障碍且伴有明显日波动的病因,也称为多巴反应性肌张力障碍(Ichinose, H., Ohye, T., Takahashi, E., Seki, N., Hori, T., Segawa, M., Nomura, Y., Endo, K., Tanaka, H., Tsuji, S., Fujita, K., and Nagatsu, T. (1994) Nature Genetics 8, 236 - 242)。为阐明调节GTP环化水解酶I基因转录并产生多种mRNA的机制,我们分离了人类和小鼠GTP环化水解酶I基因的基因组DNA克隆。对分离克隆的结构分析表明,GTP环化水解酶I基因由单拷贝基因编码,由六个外显子组成,跨度约为30千碱基。我们对人类和小鼠基因的所有外显子/内含子边界进行了测序。结构分析还表明,GTP环化水解酶I mRNA的异质性是由第六外显子剪接受体位点的选择性使用引起的。确定了小鼠GTP环化水解酶I基因的转录起始位点以及小鼠和人类基因的5'侧翼序列。我们通过荧光原位杂交对小鼠基因进行了区域定位,小鼠GTP环化水解酶I基因被定位到小鼠14号染色体的C2 - 3区域。我们在GTP环化水解酶I缺乏症患者中鉴定出错义突变,并在大肠杆菌中表达突变酶以确认酶活性的改变。